Antoñanzas Villar, Fernando; Juárez-Castelló, C. A.; … - In: Health economics review 9 (2019) 28, pp. 1-10
Background: Currently, personalised medicine is becoming more frequently used and many drug companies are including this strategy to gain market access for very specialized therapies. In this article, in order to understand the relationships between the health authority and the drug company when...